TRU
Asset Logo

Truscreen Group Limited

🇦🇺 ASX

🩺 HEALTH CARE

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-18.99%
Annual Growth

4 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

TruScreen Group Ltd. engages in the development, manufacture, and sale of cancer detection device and systems. The firm is engaged in the development of an artificial intelligence (AI)-enabled device that can detect precancerous and cancerous cervical changes in real-time via optical and electrical measurements of cervical tissue. The Company’s cervical screening technology resolves ongoing issues with cytology, including failed samples, poor patient follow-up, patient discomfort, and the need for supporting laboratory infrastructure. The TruScreen device uses opto-electrical technology to evaluate the tissue of the cervix. The TruScreen device consists of a disposable Single Use Sensor (SUS), a Handheld Device (HHD), and an Intelligent Cradle (IC) which works together to detect and identify cancerous and precancerous changes to the cervix. The company also resolves the problems associated with human papillomavirus (HPV) testing, which tests for the much more prevalent HPV virus.

📈 Performance

Price History

-72.86%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.02

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in TRU

0

📊 Total Capital Earnings

$-332.55

🔃 Average investment frequency

32 weeks

💵 Average investment amount

$820

Last time a customer invested in TRU

879 days
TRU investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in TRU also invest in...

Vanguard US Total Market Shares Index ETF

VTS

VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.

🙌 Performance (5Yr p.a)

18.17%

📊 Share price

$430.48 AUD

📈 HIGH PRICE GROWTH

⛳️ DIVERSIFIED

🤖 TECHNOLOGY

Find Out More

ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.

🙌 Performance (5Yr p.a)

9.56%

📊 Share price

$35.29 AUD

🇦🇺 EX AUSTRALIA

🩺 HEALTH CARE

🤖 TECHNOLOGY

📈 HIGH PRICE GROWTH

VESG.AX was created on 2018-09-11 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Ethically Conscious International Shares Index ETF seeks to track the return of the FTSE Developed ex Australia Choice Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax

🙌 Performance (5Yr p.a)

14.29%

📊 Share price

$94.07 AUD

🤖 TECHNOLOGY

🌏 GLOBAL

📈 HIGH PRICE GROWTH

⛳️ DIVERSIFIED

VEU.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard All-World ex-US Shares Index ETF seeks to track the return of the FTSE All-World ex US Index before taking into account fees, expenses and tax

🙌 Performance (5Yr p.a)

4.52%

📊 Share price

$92.51 AUD

⛳️ DIVERSIFIED

🌏 GLOBAL

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

🙌 Performance (5Yr p.a)

19.17%

📊 Share price

$58.19 AUD

📈 HIGH PRICE GROWTH

🇺🇸 UNITED STATES

Want more shares? Try these...

Top Shelf International Holdings Ltd. engages in manufacturing and distributes non-alcoholic and alcoholic beverages. The Company’s brands are NED Australian Whisky and Grainshaker Hand Made Australian Vodka. The firm has expertise in the development and production of distilled spirits, undertakes a significant level of research and development and operates modern fermentation, distillation and packaging facilities in Campbellfield, Victoria. The firm also provides canning, bottling, and packaging services to a range of customers. NED is a whisky in Australia that comes in both bottle and ready-to-serve formats. The Company’s maturation facilities and bond stores are located in Somerton, Victoria, and house oak vats and barrels for the storage of whisky inventory. The Company’s Agave spirit farm is situated in the Whitsundays region of Queensland.

📊 Share price

$0.04 AUD

🍔 FOOD PRODUCTS

Tissue Repair Ltd. is a clinical stage bio pharmaceutical company, which develops advanced wound healing products targeting applications in the chronic wound and aesthetic procedure aftercare markets, with the potential for further development of related technologies. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-11-18. The firm's core focus is entering Phase 3 clinical trials in chronic wounds for its lead drug candidate TR987, with a secondary focus on commercializing TR Pro+ a post procedure topical gel to accelerate healing and improve skin quality following cosmetic and medical procedures. Its TR Pro+ product provides a range of benefits that assists damaged skin to heal and maintains skin hydration for a moist healing environment to encourage normal scar formation. The firm is also focused on commercializing its propriety Glucoprime active pharmaceutical ingredient (API) to treat a variety of wounds and skin conditions. Glucoprime is a β-glucan molecule, which is designed to assist skin healing and is delivered topically in a hydrogel formulation.

📊 Share price

$0.28 AUD

🧬 BIOTECHNOLOGY

The Reject Shop Ltd. engages in retailing discount variety merchandise. The firm specializes in in curating furniture items that are on surplus clearance and factory rejects due to minor cosmetic defects. The company sells a range of furniture items that are brand new but have been rejected due to minor defects or damages during the manufacturing process. These items are sold at a lower price compared to similar products available in the market. Its product categories include dining room, living room, bedroom, outdoor, delivery options, office, luxury goods, homeware and appliance, home decor, electronics, and lighting. Its dining room products include HOVE Oval Dining Table in WALNUT, LORRAINE Outdoor Table in GREY, CHUNGHA Carrara Marble Dining Table with WALNUT Frame, BINNA Dining Table in OAK, and DALMASSE Small V-Frame Square Dining Table in NATURAL. Its luxury products include Louis Vuitton Handbag Preloved and TODS Handbag Preloved.

🙌 Performance (5Yr p.a)

0.59%

📊 Share price

$2.78 AUD

🛍️ CONSUMER

Compare
Add to watchlist